This Article Full Text Full Text (PDF) All Versions of this Article: 30/4/391    most recent Author Manuscript (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Burnett, A. L. Search for Related Content PubMed PubMed Citation Articles by Burnett, A. L.

Minireview

Erectile Dysfunction Management for the Future

From the Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland.

Correspondence to: Dr Arthur L. Burnett, Department of Urology, The Johns Hopkins Hospital, 600 North Wolfe St/Marburg 407, Baltimore, MD 21287-2411 (e-mail: aburnet1{at}jhmi.edu).

Abstract

The field of erectile dysfunction (ED) management over time has witnessed assorted interventions to enable men to perform sexual intercourse. In recent times, major progress in ED research has led to increasingly effective treatments based on a refined knowledge of the scientific basis for penile erection. Current concepts suggest that therapeutic prospects on the horizon include novel pharmacotherapies, growth factor therapy, gene therapy, and regenerative medicine. The purpose of this review is to present the foundations for future therapies in ED management.

     Key words: Pharmacotherapy, growth factor therapy, gene therapy, regenerative medicine, penis, erection